Development and validation of an HPLC‐UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV‐positive patients

Therapeutic drug monitoring may be crucial in selected clinical conditions for the management of HIV infection. In recent years, new antiretrovirals have been introduced and in particular elvitegravir (EVG) is now recommended for first‐line and simplification treatment as well as dolutegravir (DTG)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedical chromatography 2018-09, Vol.32 (9), p.e4274-n/a
Hauptverfasser:	Tempestilli, Massimo, Ammassari, Adriana, D'Avolio, Antonio, Cicalini, Stefania, Gallo, Anna Loredana, Fazio, Simone, Antinori, Andrea, Pucillo, Leopoldo P.
Format:	Artikel
Sprache:	eng
Schlagworte:	antiretrovirals elvitegravir HIV HPLC‐UV therapeutic drug monitoring
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!